Home » Korean Operations of Institute Pasteur, Sanofi-Aventis Partner to Screen for HBV Drugs

Korean Operations of Institute Pasteur, Sanofi-Aventis Partner to Screen for HBV Drugs

Nov 03, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Korean operations of Institut Pasteur and Sanofi-Aventis announced on Wednesday a collaboration to screen for new compounds directed at Hepatitis B.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Drive Away the Flies

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

Fewer Transfusions Needed

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

This Week in Nature

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Alteration Here and There to Win

Futurism writes that gene doping could be the next generation of cheating in sports.

What's Popular?

In Cell Biology Research

  1. Chan Zuckerberg Initiative to Fund Human Cell Atlas Projects

  2. Researchers Identify Essential Genes for Pluripotent Stem Cells Through CRISPR-Cas9 Screening

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.